InvestorsHub Logo
Followers 105
Posts 4947
Boards Moderated 0
Alias Born 10/20/2015

Re: GrowthStockInvestor post# 40930

Monday, 11/30/2015 2:54:56 AM

Monday, November 30, 2015 2:54:56 AM

Post# of 461142
Global Biotechnology Report. AVXL was one of 16 is special focus section out of 513 companies $4900 report went out Thurs Nov 26. See prnews wire The 16 select key players were AVXL AbbVie Bayer Phizer. GENETECH. Sandoz. Sanofi. Baxter. Ect.
So you see Missing does not need to drop bombs. A collection of professional analysts launched a number of cruse missiles on Thanksgiving day. We do not know how many reports were sold but we know the type of players that pay $4900 for reports. I postulate that all funds that invest in Pharma bought it so they know what the others know. We do not know when they will hit or how big the upward explosion but I think the first one hit Friday.
Funds like to do "window dressing" at end of year to show they are "with it" AVXL is still up 700% year to date so AVXL makes great window dressing at the least. We over take our highs by Christmas I believe then never look back. The only game shorts will have to get your shares is if you try to game it by selling around 12 or 14 to try to buy back cheaper later. Trust me that might be difficult AVXL will not repeat the dump. That is too easy. Only thing to do is buy and hold. I plan to add more and I know I will have to pay more as time goes by. AVXL even at $30 as it sits right now would extremely undervalued.
Watch and you will see big block buys this week even with no news. All the info is out there now and soon will be on the trading decks of strong hands so we do not need news but none the less we have many catalysts coming soon as well. See you all in Vegas at our Victory Party.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News